PSP Investments

PSP Investments is a leading Canadian pension investment manager with a diversified global portfolio exceeding $116.8 billion in assets under management. The company caters to the pension plans of various Canadian government entities and military branches, including the Public Service and the Royal Canadian Mounted Police. With a team of over 600 professionals, PSP Investments strategically invests in stocks, bonds, private equity, real estate, infrastructure, natural resources, and private debt. Headquartered in Ottawa, the company has business offices in Montreal, New York, London, and Luxembourg, allowing for a strong international presence and comprehensive investment management services.

Oliver Duff

Senior Vice President, Global Head of Credit Investments

Loic Jule

Managing Director - Global Investment Partnerships Portfolio

Eduard van Gelderen

SVP and Chief Investment Officer

Past deals in Hungary

Ceva Santé Animale

Private Equity Round in 2025
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.

Ceva Santé Animale

Venture Round in 2020
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.